📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
44 announcements match the current filters (relevance ≥ 5).
Max Healthcare Q4 Results: ₹2 Dividend & New 712-Bed Hospital in Lucknow
Max Healthcare has recommended a final dividend of ₹2 per share for FY26 following its board meeting. A major highlight is the approval for a new ~712-bed hospital project in Lucknow, marking a significant capacity expansion. The board also approved shifting the registered office to Gurugram and the re-appointment of Mr. Anil Kumar Bhatnagar as a director. Furthermore, a promoter group entity is seeking re-classification to the public category, indicating a potential change in shareholding structure.
Key Highlights
Final dividend of ₹2 per equity share (20% of face value) recommended for FY 2025-26.
New hospital construction approved in Shaheed Path, Lucknow with ~712 census beds on 5-acre land.
Registered office to be shifted from Mumbai, Maharashtra to Gurugram, Haryana, subject to approvals.
Re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive Director for a 3-year term starting October 2026.
Radiant Life Care Hospital Foundation to be re-classified from 'Promoter Group' to 'Public' category.
👀 What to Watch
The aggressive bed-capacity expansion in Lucknow is a positive signal for future revenue growth; long-term investors should maintain their positions. Monitor the detailed financial results for specific margin and PAT growth trends.
Max Healthcare Q4: ₹2 Dividend Declared, New 712-Bed Lucknow Hospital Approved
Max Healthcare Institute Limited announced its Q4 and FY26 financial results, recommending a final dividend of ₹2 per equity share (20% of face value). The Board approved a significant expansion project for a ~712-bed hospital in Lucknow on a 5-acre land parcel. Additionally, the company is shifting its registered office from Mumbai to Gurugram and has approved the re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category.
Key Highlights
Recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26.
Approved Phase-I construction of a new ~712-bed Max Super Specialty Hospital at Shaheed Path, Lucknow.
Shifting registered office from Mumbai, Maharashtra to Gurugram, Haryana, pending shareholder approval.
Approved the re-classification of Radiant Life Care Hospital Foundation to the 'Public' category.
Re-appointed Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a 3-year term.
👀 What to Watch
Investors should note the significant capacity expansion in Lucknow as a long-term growth driver and the ₹2 dividend as a positive yield signal. Monitor the upcoming AGM for final approvals on the dividend and the registered office relocation.
Max Healthcare to Build 712-Bed Lucknow Hospital; Declares ₹2 Dividend
Max Healthcare has announced a major expansion with the approval of a 712-bed hospital in Lucknow, significantly boosting its future capacity. The board also recommended a final dividend of ₹2 per share for FY26, rewarding shareholders. Administratively, the company is shifting its registered office from Mumbai to Gurugram and reclassifying a promoter entity to the public category. These developments reflect a mix of aggressive infrastructure growth and corporate restructuring.
Key Highlights
Recommended a final dividend of ₹2 per equity share (20% of face value) for FY 2025-26.
Approved construction of Phase-I of a new hospital in Lucknow with a capacity of ~712 census beds.
Proposed shifting of the registered office from Mumbai, Maharashtra to Gurugram, Haryana.
Approved re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category.
Re-appointed Mr. Anil Kumar Bhatnagar as Non-Executive Director for a 3-year term starting October 2026.
👀 What to Watch
Investors should monitor the execution timelines of the Lucknow hospital project as it represents a significant capacity addition. The dividend and office consolidation are positive signs of financial health and operational streamlining.
Max Healthcare Q4 Revenue Rises 10% to ₹2,664 Cr; FY26 PAT Jumps 22% to ₹1,631 Cr
Max Healthcare reported a steady Q4 FY26 with revenue growing 10% YoY to ₹2,664 crore and PAT rising 3% to ₹387 crore. For the full year FY26, the company showed stronger momentum with revenue up 16% to ₹10,538 crore and PAT increasing 22% to ₹1,631 crore. The company is in an aggressive expansion phase, having commissioned 20% additional brownfield capacity recently and approving a new ₹1,400 crore greenfield project in Lucknow. Operational metrics remain robust with an ARPOB of ₹77.9k and 75% occupancy, though margins saw slight compression due to higher clinician hiring costs.
Key Highlights
Network Gross Revenue for FY26 reached ₹10,538 Cr, a 16% YoY growth, while Q4 revenue grew 10% to ₹2,664 Cr.
Full-year PAT grew 22% YoY to ₹1,631 Cr, supported by a one-time tax gain of ₹142 Cr in Q2 FY26.
Phased commissioning of ~20% brownfield capacity completed in the last six months, with another 10% expected by year-end.
Acquisition of 58.28% stake in Kalinga Hospital (250 beds) in Bhubaneswar was completed on May 18, 2026.
Board approved a ₹1,400 Cr investment for a new 712-bed greenfield hospital at Shaheed Path, Lucknow.
👀 What to Watch
Investors should focus on the company's aggressive capacity expansion and M&A strategy which provides high visibility for future revenue growth. While short-term margins may be impacted by the ramp-up of new beds and clinical talent hiring, the long-term outlook remains strong given the high ARPOB and expansion into under-served markets.
Max Healthcare Q4 Revenue Rises 10% to ₹2,664 Cr; PAT Grows to ₹387 Cr
Max Healthcare reported a steady Q4 FY26 with gross revenue growing 10% YoY to ₹2,664 Cr and Network Operating EBITDA rising 8% to ₹682 Cr. For the full year FY26, the company achieved a 16% revenue growth and a 22% surge in PAT to ₹1,631 Cr. The company is in an aggressive expansion phase, having commissioned 20% additional brownfield capacity in the last six months and announcing a new ₹1,400 Cr greenfield hospital in Lucknow. Strategic growth is further bolstered by the recent acquisition of a controlling stake in Kalinga Hospital, Bhubaneswar.
Key Highlights
Q4 FY26 Gross Revenue stood at ₹2,664 Cr (+10% YoY) with Bed Occupancy at 75%.
Network Operating EBITDA for Q4 reached ₹682 Cr, though margins slightly compressed to 26.8% due to aggressive clinical hiring.
Acquisition of 58.28% stake in Kalinga Hospital (250 beds) in Bhubaneswar was completed on May 18, 2026.
Board approved a ₹1,400 Cr investment for a 712-bed greenfield hospital at Shaheed Path, Lucknow.
Free Cash from Operations for Q4 FY26 increased to ₹581 Cr compared to ₹422 Cr in Q4 FY25.
👀 What to Watch
Investors should focus on the company's successful execution of its brownfield expansion and its entry into new markets like Odisha. While clinical talent costs have slightly impacted margins, the long-term growth trajectory remains strong given the massive capacity additions and robust cash flow.
Max Healthcare Recommends ₹2 Dividend; Plans 712-Bed Hospital Expansion in Lucknow
Max Healthcare has recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26. A major strategic highlight is the board's approval for the construction of a new 712-bed super specialty hospital in Lucknow on a 5-acre land parcel. Additionally, the company is shifting its registered office to Gurugram and re-classifying a promoter group entity to the public category. These moves signal a combination of shareholder returns and aggressive capacity expansion.
Key Highlights
Recommended a final dividend of ₹2 per equity share for the financial year ended March 31, 2026.
Approved construction of Phase-I of Max Super Specialty Hospital in Lucknow with ~712 census beds.
Shifting of registered office from Mumbai, Maharashtra to Gurugram, Haryana approved subject to AGM.
Re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category.
Re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive Director for a 3-year term.
👀 What to Watch
Investors should view the massive 712-bed expansion in Lucknow as a significant long-term growth driver for the company's bed capacity. The dividend provides a steady return while the company continues to invest heavily in infrastructure.
Max Healthcare Recommends ₹2 Dividend; Plans 712-Bed Hospital Expansion in Lucknow
Max Healthcare has recommended a final dividend of ₹2 per share (20% of face value) for the financial year 2025-26. A major growth initiative was approved for the construction of a new hospital in Lucknow with a capacity of approximately 712 beds on a 5-acre land parcel. The company is also shifting its registered office to Gurugram and has approved the re-classification of a promoter group entity to the public category.
Key Highlights
Recommended a final dividend of ₹2 per equity share for the financial year ended March 31, 2026.
Approved construction of Phase-I of Max Super Specialty Hospital, Lucknow, featuring ~712 census beds.
Re-appointed Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a 3-year term.
Approved shifting the registered office from Mumbai, Maharashtra to Gurugram, Haryana.
Approved the re-classification request of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public'.
👀 What to Watch
Investors should view the massive 712-bed expansion in Lucknow as a strong signal of long-term growth and capacity building. The dividend recommendation provides immediate value, and the stock remains a key play in the consolidating Indian healthcare sector.
Max Healthcare Named in NCLT Petition Over Newly Acquired Kalinga Hospital
Max Healthcare Institute Limited has been named as a party in a petition filed before the NCLT Cuttack Bench by BRS Capital Two Pte. Limited. The petition alleges oppression and mismanagement in Kalinga Hospital Ltd (KHL), a company where Max Healthcare completed a 58.28% majority stake acquisition on May 18, 2026. The NCLT has heard arguments regarding interim reliefs and reserved its order, with the next hearing scheduled for July 7, 2026. The company stated that the expected financial implications cannot be anticipated at this stage.
Key Highlights
Max Healthcare completed the acquisition of a 58.28% stake in Kalinga Hospital Ltd on May 18, 2026.
A petition was filed on May 19, 2026, by minority shareholder BRS Capital Two Pte. Limited alleging oppression and mismanagement.
The NCLT Cuttack Bench has reserved its orders on interim reliefs and directed parties to file written submissions.
The next hearing for the ongoing legal dispute is scheduled for July 7, 2026.
👀 What to Watch
Investors should closely monitor the NCLT's upcoming order on interim reliefs to see if it disrupts Max Healthcare's operational control or integration of Kalinga Hospital.
Max Healthcare Acquires 58.28% Stake in Kalinga Hospital for ₹297.97 Crore
Max Healthcare Institute Limited has completed the acquisition of a 58.28% controlling stake in Kalinga Hospital Limited (KHL) for an aggregate consideration of approximately ₹297.97 Crore. KHL operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha, marking a significant geographic expansion for the company. The acquisition was funded through a Senior Secured Term Loan of ₹300 Crore via External Commercial Borrowings (ECB). Consequently, KHL has officially become a subsidiary of Max Healthcare as of May 18, 2026.
Key Highlights
Acquired ~58.28% equity stake in Kalinga Hospital Ltd for ~₹297.97 Crore
KHL operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha
Financed the acquisition through a ₹300 Crore Senior Secured Term Loan (ECB)
Kalinga Hospital Ltd has officially become a subsidiary of Max Healthcare
Strategic entry into the Odisha market to strengthen regional presence
👀 What to Watch
Investors should view this as a positive growth move that expands the company's footprint into Eastern India. Monitor the integration of KHL and its impact on the company's consolidated occupancy and EBITDA margins.
Max Healthcare Shareholders Approve Re-appointment of Director with 91.07% Majority
Max Healthcare Institute Limited has announced the results of its postal ballot held via remote e-voting on May 11, 2026. Shareholders approved the ordinary resolution for the re-appointment of Mr. Narayan K. Seshadri as a Non-Executive and Non-Independent Director. The resolution passed with a 91.07% majority, with 79.71 crore votes in favor and 7.81 crore votes against. Mr. Seshadri has been re-appointed for a period of 3 years from May 16, 2026, to May 15, 2029.
Key Highlights
Ordinary resolution passed with 91.0674% votes in favor (79,71,85,401 votes).
Dissenting votes stood at 8.9326% representing 7,81,94,098 votes.
Mr. Narayan K. Seshadri re-appointed as Non-Executive and Non-Independent Director for 3 years.
Total paid-up share capital of the company stands at Rs. 973.19 crore divided into 97.31 crore equity shares.
A total of 1,568 members participated in the e-voting process which concluded on May 11, 2026.
👀 What to Watch
This is a routine corporate governance update confirming the continuation of existing leadership. No immediate action is required from investors as the continuity in the board is expected to maintain strategic stability.
Max Healthcare: GST Authority Withdraws ₹55.2 Crore Tax Demand
Max Healthcare Institute Limited has received a favorable Rectification Order from the GST Department in New Delhi. The authority has withdrawn a previously raised tax demand of ₹55.20 crore related to alleged excess Input Tax Credit. This follows a rectification application filed by the company against an order dated December 30, 2025. The total withdrawal of the demand removes a potential financial liability for the company.
Key Highlights
GST authority has withdrawn the entire demand of ₹55,20,45,266 raised against the company.
The dispute originated from an order dated December 30, 2025, regarding excess Input Tax Credit.
The Rectification Order was received from the Office of the GST Officer, Ward 96, New Delhi.
The authority accepted the company's submissions, resulting in zero penalty or compensation.
👀 What to Watch
The withdrawal of the ₹55.2 crore demand is a positive outcome that eliminates a potential financial risk. Investors should view this as a successful resolution of a regulatory dispute.
Max Healthcare to Acquire 58.4% Stake in Kalinga Hospital for ₹300 Crore
Max Healthcare is expanding its footprint into Eastern India by acquiring a 58.39% stake in the 250-bed Kalinga Hospital in Bhubaneswar for ₹300 crore. The acquisition includes a prime 10-acre land parcel with significant brownfield potential to expand capacity to over 1,000 beds. To finance this, the board has approved a ₹300 crore External Commercial Borrowing (ECB) and an additional ₹100 crore loan for hospital infrastructure upgrades. Kalinga Hospital showed strong growth with FY25 revenues reaching ₹135.63 crore compared to ₹105.65 crore in FY24.
Key Highlights
Acquisition of 58.39% stake in Kalinga Hospital Ltd for an equity value of ₹300 Crore.
Target facility is a 250-bed NABH accredited hospital with potential to scale to 1,000+ beds on a 10-acre campus.
KHL revenue grew 28% year-on-year to ₹135.63 Crore in FY25.
Approved ₹300 Crore Senior Secured Term Loan (ECB) from Standard Chartered Bank to fund the deal.
Additional ₹100 Crore loan approved for KHL's renovation, upgradation, and equipment costs.
👀 What to Watch
This acquisition is a strategic entry into the high-growth Odisha market with massive brownfield expansion potential. Investors should view this as a long-term value creator and monitor the integration and capacity ramp-up timelines.
Max Healthcare to acquire 58.4% stake in Kalinga Hospital for ₹300 Crore
Max Healthcare Institute Limited (MHIL) has entered into a share purchase agreement to acquire a 58.4% controlling stake in Kalinga Hospital Limited (KHL) for an equity value of ₹300 Crore. KHL operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha, and reported a revenue of ₹135.63 Crore in FY 2024-25. The acquisition includes a 10-acre land parcel, offering significant brownfield potential to expand the facility to over 1,000 beds. To support this, MHIL has approved ₹300 Crore in External Commercial Borrowings and will provide a ₹100 Crore loan for hospital renovation and upgradation.
Key Highlights
Acquisition of 58.4% stake in Kalinga Hospital Ltd for ₹300 Crore equity value.
Target hospital has 250 beds with potential to expand to 1,000+ beds on a 10-acre campus.
KHL's revenue grew significantly from ₹90.39 Crore in FY23 to ₹135.63 Crore in FY25.
Approved ₹300 Crore in External Commercial Borrowings (ECB) to finance the acquisition.
Additional ₹100 Crore loan approved for KHL's renovation and equipment upgradation.
👀 What to Watch
Investors should view this as a strategic entry into the high-growth Eastern India market with substantial long-term expansion potential. Monitor the integration and the timeline for the brownfield expansion to 1,000 beds as key value drivers.
Max Healthcare to Acquire 58.4% Stake in Kalinga Hospital for ₹300 Crore
Max Healthcare is expanding its footprint into Eastern India by acquiring a 58.39% controlling stake in the 250-bed Kalinga Hospital in Bhubaneswar for an equity value of ₹300 Crore. The acquisition includes a prime 10-acre land parcel, offering significant brownfield potential to expand the facility to over 1,000 beds. To support the acquisition and subsequent upgrades, the board has approved ₹300 Crore in External Commercial Borrowings and an additional ₹100 Crore loan for hospital renovation. Kalinga Hospital demonstrated strong growth with FY25 revenue reaching ₹135.63 Crore, up from ₹90.39 Crore in FY23.
Key Highlights
Acquisition of 58.39% stake in Kalinga Hospital Ltd for ₹300 Crore equity value.
Immediate addition of 250 beds with long-term potential to scale to 1,000+ beds on a 10-acre campus.
Target company revenue grew from ₹90.39 Crore in FY23 to ₹135.63 Crore in FY25.
Board approved ₹300 Crore ECB for financing and up to ₹100 Crore loan for facility upgradation.
Strategic entry into the Bhubaneswar market, serving Odisha, West Bengal, Jharkhand, and Chhattisgarh.
👀 What to Watch
Investors should view this as a high-growth strategic expansion that provides Max Healthcare with a solid entry point into Eastern India. The significant land bank for future expansion suggests long-term value creation beyond the immediate 250-bed addition.
Max Healthcare to acquire 58.4% stake in Kalinga Hospital for ₹300 Crore
Max Healthcare has entered into a share purchase agreement to acquire a 58.39% controlling stake in Kalinga Hospital Limited (KHL) in Bhubaneswar for ₹300 Crore. This acquisition marks the company's entry into the Odisha market, utilizing a 250-bed facility with significant brownfield potential to expand to over 1,000 beds on its 10-acre campus. The transaction will be funded through a ₹300 Crore External Commercial Borrowing (ECB) from Standard Chartered Bank. Additionally, the board approved a ₹100 Crore loan for KHL's infrastructure upgrades and re-appointed Narayan K. Seshadri as a director for three years.
Key Highlights
Acquisition of 58.39% stake in Kalinga Hospital Ltd for an equity value of ₹300 Crore.
Target hospital is a 250-bed NABH accredited facility in Bhubaneswar with FY25 revenue of ₹135.63 Crore.
Strategic 10-acre land parcel allows for long-term expansion potential to over 1,000 beds.
Financing secured via a ₹300 Crore Senior Secured Term Loan (ECB) from Standard Chartered Bank.
Board approved an additional ₹100 Crore loan to KHL for renovation and infrastructure upgrades.
👀 What to Watch
This acquisition is a strategic entry into the high-growth Eastern India market with massive brownfield expansion potential. Investors should maintain a positive outlook as the company continues to deploy capital for inorganic growth and capacity addition.
Max Healthcare Reports 38% EBITDA CAGR and ₹1.02 Lakh Cr Market Cap in Investor Update
Max Healthcare showcased its position as India's largest hospital chain by market cap (₹1.02 lakh crore) with a strong 4-year EBITDA CAGR of 38% and Revenue CAGR of 24%. The company currently operates over 5,200 beds across 20 facilities, maintaining a high occupancy rate of 76% and a robust ROCE of 26% for 9M FY26. Growth is being driven by aggressive inorganic expansion, including recent acquisitions in Lucknow, Nagpur, and Noida, alongside significant brownfield expansions in Mumbai and Mohali.
Key Highlights
Achieved a 38% EBITDA CAGR and 24% Revenue CAGR over the last 4 years (FY21-FY25)
Current capacity exceeds 5,200 beds with 73% located in high-demand metro areas
Maintained a strong Return on Capital Employed (ROCE) of approximately 26% for 9M FY26
Institutional investors (FIIs and DIIs) hold a combined stake of over 71% as of December 2025
Ongoing expansion includes a 160-bed tower in Mohali and a 268-bed tower at Nanavati-Max
👀 What to Watch
Investors should focus on the company's ability to maintain high ROCE while aggressively scaling bed capacity through both greenfield and inorganic routes. The stock remains a core play in the premium healthcare segment, though monitoring the integration of newly acquired assets like Sahara and Jaypee hospitals is essential.
Max Healthcare Q3 Revenue Up 10% YoY to INR 2,608 Cr; EBITDA Margin at 26.1%
Max Healthcare reported a 10% YoY revenue growth to INR 2,608 crore for Q3 FY26, although operating EBITDA margins contracted to 26.1% from 27.3% YoY. Performance was impacted by transitory factors including a temporary disruption in cashless services with insurers and revised CGHS pricing for chemotherapy drugs. Despite these headwinds, occupancy remained healthy at 74% on an expanded bed base, and ARPOB grew 3% YoY to INR 77,900. The company continues its aggressive expansion with new beds commissioned in Mumbai and Mohali, and a board-approved 260-bed addition at Max Dwarka.
Key Highlights
Gross revenue increased 10% YoY to INR 2,608 crore, while operating EBITDA grew 4% to INR 648 crore.
Average Revenue Per Occupied Bed (ARPOB) reached INR 77,900, reflecting a 3% YoY growth.
International patient revenue grew 14% YoY, now accounting for 9% of total hospital revenue.
Brownfield expansion is on track with 116 beds commissioned across Nanavati and Mohali units in Q3.
Net debt-to-EBITDA remains conservative at less than 1x, with INR 281 crore free cash flow generated during the quarter.
👀 What to Watch
Investors should focus on the ramp-up of newly commissioned beds and the restoration of insurance contracts which are expected to normalize margins in Q4. The stock remains a strong long-term play given the robust 4,000+ bed expansion pipeline through FY29.
Max Healthcare Reports 38% EBITDA CAGR; Market Cap Reaches ₹1.02 Lakh Crore
Max Healthcare Institute Limited (MAXHEALTH) released its latest investor presentation, highlighting its position as India's largest hospital chain by market capitalization at ₹1.02 lakh crore. The company demonstrated robust financial performance with a 4-year EBITDA CAGR of 38% and a revenue CAGR of 24%. Operational efficiency remains high with a 9M FY26 occupancy rate of approximately 76% and a Return on Capital Employed (ROCE) of 26%. The presentation outlines a massive expansion pipeline across Delhi NCR, Mumbai, Lucknow, and Pune to further scale its 5,200+ bed capacity.
Key Highlights
Market capitalization stands at ₹1.02 lakh crore ($11.3 billion) as of December 31, 2025.
Achieved a 38% EBITDA CAGR and 24% Revenue CAGR over the last 4 years.
Current capacity exceeds 5,200 beds across 20 facilities with 73% of beds located in metro cities.
Maintained strong operational metrics with ~76% occupancy and ~26% ROCE for 9M FY26.
Significant expansion pipeline includes a ~1,000-bed project in Gurugram and a ~450-bed hospital development in Pune.
👀 What to Watch
Investors should note the company's industry-leading ROCE and consistent EBITDA growth as evidence of high operational efficiency. The aggressive expansion roadmap across high-demand metros provides a clear long-term growth runway for the stock.
Max Healthcare Q3 Revenue Up 10% to ₹2,608 Cr; PAT Grows 9% to ₹344 Cr
Max Healthcare reported a steady Q3 FY26 with gross revenue rising 10% YoY to ₹2,608 Cr, supported by a 7% growth in occupied bed days. Network Operating EBITDA grew 4% YoY to ₹648 Cr, though margins saw a slight compression to 26.1% due to pre-commissioning expenses and regulatory shifts. PAT increased 9% YoY to ₹344 Cr, even after accounting for ₹55 Cr in exceptional items related to labor codes and stamp duties. The company is actively expanding, having commissioned new beds in Mohali and Mumbai while announcing a new 450-bed project in Pune.
Key Highlights
Gross Revenue grew 10% YoY to ₹2,608 Cr; Network PAT increased 9% YoY to ₹344 Cr.
ARPOB improved to ₹77.9k from ₹75.9k YoY, while bed occupancy stood at 74%.
Successfully commissioned 53 beds in Mohali and 63 beds in Nanavati Max with healthy initial margins of 39% and 31% respectively.
Announced staggered acquisition of Yerawada Properties in Pune for a new ~450-bed hospital project.
Exceptional charges of ₹55 Cr impacted the bottom line, alongside temporary headwinds from CGHS tariff revisions and drug pricing guidelines.
👀 What to Watch
Investors should monitor the ramp-up of newly commissioned brownfield beds which are already delivering accretive margins. The company's aggressive expansion into Pune and Delhi NCR reinforces its long-term growth trajectory in the premium healthcare segment.
Max Healthcare Q3 Revenue Grows 10% to ₹2,608 Cr; PAT Up 9% to ₹344 Cr
Max Healthcare reported a steady Q3 FY26 with a 10% YoY revenue growth to ₹2,608 Cr and a 9% rise in PAT to ₹344 Cr, despite ₹55 Cr in exceptional charges. Operating margins compressed slightly to 26.1% from 27.3% due to pre-commissioning expenses for new beds and regulatory impacts on institutional drug pricing. The company is aggressively expanding, with new brownfield beds already operational in Mohali and Nanavati showing strong initial margins. Operational metrics remain healthy with ARPOB increasing to ₹77.9k and bed occupancy at 74%.
Key Highlights
Gross Revenue grew 10% YoY to ₹2,608 Cr, while Network Operating EBITDA rose 4% YoY to ₹648 Cr.
PAT increased 9% YoY to ₹344 Cr after accounting for ₹55 Cr in exceptional items related to wage codes and stamp duty.
ARPOB (Average Revenue Per Occupied Bed) improved to ₹77.9k, while bed occupancy stood at 74%.
Newly commissioned beds in Mohali (53 beds) and Nanavati (63 beds) delivered healthy EBITDA margins of 39% and 31% respectively.
Announced a new 450-bed hospital project in Pune via the acquisition of Yerawada Properties Pvt. Ltd.
👀 What to Watch
Investors should view the slight margin compression as temporary due to expansion costs, while focusing on the strong performance of newly commissioned beds. The company's aggressive capacity addition and entry into the Pune market provide a clear roadmap for long-term growth.
